Rheumatoid Arthritis (RA) Moderate to Low Disease Activity Study

NCT00674362 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

194

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

BIOLOGICAL: Certolizumab pegol
BIOLOGICAL: Placebo

Sponsor

UCB Pharma